Gedeon Richter’s biosimilar for osteoporosis available on NHS
Gedeon Richter has announced that its biosimilar for osteoporosis, Terrosa® (teriparatide), is available on the NHS for the treatment of osteoporosis in postmenopausal women...
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
ABPI says prioritise ‘vaccine hesitancy’ as UK loses measles-free status
Responding to the news that the UK Prime Minister has committed to improving declining vaccination rates, Dr Sheuli Porkess, Executive Director at the ABPI,...
AbbVie receives FDA approval of RINVOQ™
The U.S. Food and Drug Administration (FDA) has approved AbbVie's RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment...
Compliance and transparency excellence in life sciences
EuroEvents has launched the inaugural Compliance and Transparency Excellence in Life Sciences Conference on 26 and 27 September in Amsterdam, The Netherlands. As a heavily...
Tillotts Pharma UK recognised for supporting nurses education in the NHS.
Tillotts Pharma UK, specialist gastrointestinal (GI) health company excelled in its achievements during the first half of 2019 winning Gold and Silver at the...
Lynparza in combination increases survival time in women with ovarian cancer
AstraZeneca and MSD have announced positive results from the Phase III PAOLA-1 trial in women with advanced ovarian cancer. The trial, in the 1st-line maintenance...
Scientists reverse the ageing process in stem cells – brain ‘stiffening’ to blame
New research, published in Nature, reveals how increasing brain stiffness as we age causes brain stem cell dysfunction, and demonstrates new ways to reverse...
AstronauTx secures £6.5m for new approaches to dementia therapeutics
A new UK-based biotech company, AstronauTx Ltd, which builds on the work from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received...
Aspen proposes package to resolve competition concerns over fludrocortisone supply
Drug firm Aspen has offered to pay the NHS £8m, as part of a wider package, to resolve competition concerns over fludrocortisone supply. This follows...
Latest articles
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Licensing status of Avastin updated by MHRA
The licensing status of Avastin has been updated by the Medicines and Healthcare products Regulatory Agency (MHRA). The update concerns the licensing status of Avastin (bevacizumab)...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
Poor diabetes control costs the NHS £3bn in avoidable treatment
New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Drug firms admit to colluding to keep up prices of antidepressants
Drug firms admit to colluding in order to keep up prices of antidepressants according to the Competition and Markets Authority (CMA). Two suppliers of the...